Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Public Health and Dermatology “ From Policy to Pox, 1/22/2021 8:00:00 AM - 1/22/2024 9:00:00 AM, Dr. Lushniak enthusiastically supports public health theory from surveillance to response, as a way to prevent risk, and promote and prolong good health. He cites the regulation of tanning beds as an example of how physicians can influence health policy and compliance with a call to action to limit or eliminate access to a carcinogenic hazard. He cites anthrax and smallpox as examples of bioterrorism where dermatologists may have early warning to a potential outbreak or occupational threat and have an integral role to play in public health.
Presenter
Boris D. Lushniak, MD, MPH
Dean and Professor, University of Maryland School of Public Health
Rear Admiral (retired), US Public Health Service
About our Presenter
Rear Admiral (retired) Boris D. Lushniak, MD, MPH received his BS and MD from Northwestern University, his MPH from Harvard, and completed residencies in family medicine and dermatology. He began his US Public Health Service (USPHS) career in the Epidemic Intelligence Service and was part of the team at Ground Zero and the CDC anthrax team. He has served as the Department Chair of Preventive Medicine and Professor of Dermatology at the Uniformed Services University, was the US Deputy Surgeon General (SG) from 2010-15, and Acting SG from 2013-14. During the Ebola response in 2015 he commanded the USPHS Monrovia Medical Unit in Liberia.
Learning Outcome(s)
Participants will be able to discuss the public health environment and our role as physicians in that environment, name the core public health functions as they apply to emerging threats and identify the main public health bio threats with dermatologic features.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual™s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Boris D. Lushniak, MD, MPH
Dean and Professor, University of Maryland School of Public Health
Rear Admiral (retired), US Public Health Service
About our Presenter
Rear Admiral (retired) Boris D. Lushniak, MD, MPH received his BS and MD from Northwestern University, his MPH from Harvard, and completed residencies in family medicine and dermatology. He began his US Public Health Service (USPHS) career in the Epidemic Intelligence Service and was part of the team at Ground Zero and the CDC anthrax team. He has served as the Department Chair of Preventive Medicine and Professor of Dermatology at the Uniformed Services University, was the US Deputy Surgeon General (SG) from 2010-15, and Acting SG from 2013-14. During the Ebola response in 2015 he commanded the USPHS Monrovia Medical Unit in Liberia.
Learning Outcome(s)
Participants will be able to discuss the public health environment and our role as physicians in that environment, name the core public health functions as they apply to emerging threats and identify the main public health bio threats with dermatologic features.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee member role was resolved by altering the individual™s control over content about the products or services of the commercial interest by Marc Bertrand, MD, Associate Dean for GME (as alternate for vacant Associate Dean for CME position). All potential conflict(s) were resolved.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
